Shanjin Cao
Plus aucun poste en cours
Profil
Shanjin Cao served as the Chief Scientific Officer at LeukoSight, Inc. from 2007 to 2011.
Prior to that, Cao earned a doctorate degree from the University of Maryland.
Anciens postes connus de Shanjin Cao
| Sociétés | Poste | Fin |
|---|---|---|
LeukoSight, Inc.
 LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology LeukoSight, Inc. develops therapeutics to treat autoimmune and inflammatory diseases. Its categories include apnea, Canadian health and care mall, Canadian pharmacy mall, chronic obstructive airway disease and erectile dysfunction. The company was founded by David M. Mosser in 2007 and is headquartered in College Park, MD. | Directeur Technique/Scientifique/R&D | 20/04/2011 |
Formation de Shanjin Cao
| University of Maryland | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
LeukoSight, Inc.
LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology LeukoSight, Inc. develops therapeutics to treat autoimmune and inflammatory diseases. Its categories include apnea, Canadian health and care mall, Canadian pharmacy mall, chronic obstructive airway disease and erectile dysfunction. The company was founded by David M. Mosser in 2007 and is headquartered in College Park, MD. | Health Technology |
